Palacios Wealth Management LLC Buys Shares of 41,624 Clover Health Investments, Corp. (NASDAQ:CLOV)

Palacios Wealth Management LLC bought a new stake in Clover Health Investments, Corp. (NASDAQ:CLOV) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 41,624 shares of the company’s stock, valued at approximately $131,000.

Several other hedge funds have also recently added to or reduced their stakes in the stock. Ballentine Partners LLC acquired a new position in Clover Health Investments in the fourth quarter valued at about $131,000. SignalPoint Asset Management LLC increased its holdings in shares of Clover Health Investments by 6.2% in the fourth quarter. SignalPoint Asset Management LLC now owns 160,074 shares of the company’s stock worth $504,000 after acquiring an additional 9,390 shares in the last quarter. Steph & Co. increased its holdings in shares of Clover Health Investments by 33.3% in the fourth quarter. Steph & Co. now owns 20,000 shares of the company’s stock worth $63,000 after acquiring an additional 5,000 shares in the last quarter. Graypoint LLC bought a new stake in shares of Clover Health Investments in the fourth quarter worth about $632,000. Finally, Silverleafe Capital Partners LLC increased its holdings in shares of Clover Health Investments by 182.9% in the fourth quarter. Silverleafe Capital Partners LLC now owns 45,000 shares of the company’s stock worth $142,000 after acquiring an additional 29,091 shares in the last quarter. Institutional investors and hedge funds own 19.77% of the company’s stock.

Clover Health Investments Price Performance

Shares of Clover Health Investments stock opened at $4.54 on Friday. Clover Health Investments, Corp. has a 1 year low of $0.61 and a 1 year high of $4.87. The business has a 50-day moving average of $3.76 and a two-hundred day moving average of $3.38. The company has a market capitalization of $2.28 billion, a P/E ratio of -22.70 and a beta of 1.99.

Analyst Ratings Changes

Separately, Craig Hallum started coverage on Clover Health Investments in a report on Tuesday, December 17th. They issued a “buy” rating and a $6.00 price target for the company.

Clover Health Investments Company Profile

Clover Health Investments, Corp. provides medicare advantage plans in the United States. It operates through two segments: Insurance and Non-Insurance. It also offers Clover Assistant, a cloud-based software platform, that enables physicians to detect, identify, and manage chronic diseases earlier; and access to data-driven and personalized insights for the patients they treat.